Correction: EnVVeno Medical Prices $15 Million Public Offering
Dow Surges Over 100 Points; Costco Earnings Top Views
Traders Digest Fed's Preferred Inflation Metric as US Equity Futures Waver Pre-Bell
Cassava Sciences, EnVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Top Premarket Decliners
EnVVeno Medical Stock Falls After It Prices $15M Securities Offering
Costco, Scholastic And 3 Stocks To Watch Heading Into Friday
EnVVeno Medical 4.3M Share Spot Secondary Priced at $3.50
12 Health Care Stocks Moving In Thursday's After-Market Session
EnVVeno Medical Corporation Announces Proposed Public Offering
EnVVeno Medical Adds Sandy Prietto to Its Executive Team as Vice President of Marketing
EnVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
Here's Why We're Not Too Worried About EnVVeno Medical's (NASDAQ:NVNO) Cash Burn Situation
Express News | EnVVeno Medical Q2 2024 GAAP EPS $(0.31), Inline
EnVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
10-Q: Q2 2024 Earnings Report
EnVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Market-Moving News for June 21st
Express News | EnVVeno Medical Shares Are Trading Higher After the Company Reported Interim Venous Ulcer Healing Data From the SAVVE U.E. Pivotal Trial for VenoValve, Which Will Be Presented at the Society for Vascular Surgery 2024 Annual Meeting
Positive Interim Venous Ulcer Healing Data Showing Significant Improvement From the EnVVeno Medical VenoValve(R) Pivotal Trial to Be Presented Today at the Society for Vascular Surgery 2024 Vascular Annual Meeting